Cover Image
市場調查報告書

Dongkook Pharmaceutical Co., Ltd.:產品平台分析

Dongkook Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 306087
出版日期 內容資訊 英文 23 Pages
訂單完成後即時交付
價格
Back to Top
Dongkook Pharmaceutical Co., Ltd.:產品平台分析 Dongkook Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014
出版日期: 2014年06月15日 內容資訊: 英文 23 Pages
簡介

本報告提供Dongkook Pharmaceutical Co., Ltd.的治療藥開發平台現狀及各開發階段比較分析,彙整藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Dongkook Pharmaceutical Co., Ltd.的基本資料

Dongkook Pharmaceutical Co., Ltd.概要

  • 主要資訊
  • 企業資料

Dongkook Pharmaceutical Co., Ltd.:R&D概要

  • 主要的治療範圍

Dongkook Pharmaceutical Co., Ltd.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Dongkook Pharmaceutical Co., Ltd.:開發中產品概況

  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Dongkook Pharmaceutical Co., Ltd.:藥物簡介

  • goserelin biosimilar
  • triptorelin pamoate biosimilar
  • Asiaticoside Derivatives
  • Gene Re-Combination Proteins
  • Peptide Antibiotics

Dongkook Pharmaceutical Co., Ltd.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Dongkook Pharmaceutical Co., Ltd.:暫停中的計劃

Dongkook Pharmaceutical Co., Ltd.:總公司和子公司的所地

附錄

目錄
Product Code: GMDHC05009CDB

Global Markets Direct's, 'Dongkook Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the Dongkook Pharmaceutical Co., Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Dongkook Pharmaceutical Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Dongkook Pharmaceutical Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Dongkook Pharmaceutical Co., Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Dongkook Pharmaceutical Co., Ltd.'s pipeline products

Reasons to buy

  • Evaluate Dongkook Pharmaceutical Co., Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Dongkook Pharmaceutical Co., Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Dongkook Pharmaceutical Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Dongkook Pharmaceutical Co., Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Dongkook Pharmaceutical Co., Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Dongkook Pharmaceutical Co., Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Dongkook Pharmaceutical Co., Ltd. Snapshot
    • Dongkook Pharmaceutical Co., Ltd. Overview
    • Key Information
    • Key Facts
  • Dongkook Pharmaceutical Co., Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Dongkook Pharmaceutical Co., Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Dongkook Pharmaceutical Co., Ltd. - Pipeline Products Glance
    • Dongkook Pharmaceutical Co., Ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Dongkook Pharmaceutical Co., Ltd. - Drug Profiles
    • goserelin biosimilar
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • triptorelin pamoate biosimilar
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Asiaticoside Derivatives
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Gene Re-Combination Proteins
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Peptide Antibiotics
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Dongkook Pharmaceutical Co., Ltd. - Pipeline Analysis
  • Dongkook Pharmaceutical Co., Ltd. - Pipeline Products by Target
  • Dongkook Pharmaceutical Co., Ltd. - Pipeline Products by Route of Administration
  • Dongkook Pharmaceutical Co., Ltd. - Pipeline Products by Molecule Type
  • Dongkook Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action
  • Dongkook Pharmaceutical Co., Ltd. - Dormant Projects
  • Dongkook Pharmaceutical Co., Ltd. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Dongkook Pharmaceutical Co., Ltd., Key Information
  • Dongkook Pharmaceutical Co., Ltd., Key Facts
  • Dongkook Pharmaceutical Co., Ltd. - Pipeline by Indication, 2014
  • Dongkook Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2014
  • Dongkook Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2014
  • Dongkook Pharmaceutical Co., Ltd. - Preclinical, 2014
  • Dongkook Pharmaceutical Co., Ltd. - Discovery, 2014
  • Dongkook Pharmaceutical Co., Ltd. - Pipeline by Target, 2014
  • Dongkook Pharmaceutical Co., Ltd. - Pipeline by Route of Administration, 2014
  • Dongkook Pharmaceutical Co., Ltd. - Pipeline by Molecule Type, 2014
  • Dongkook Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action, 2014
  • Dongkook Pharmaceutical Co., Ltd. - Dormant Developmental Projects,2014

List of Figures

  • Dongkook Pharmaceutical Co., Ltd. - Pipeline by Top 10 Indication, 2014
  • Dongkook Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2014
  • Dongkook Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2014
  • Dongkook Pharmaceutical Co., Ltd. - Pipeline by Top 10 Route of Administration, 2014
  • Dongkook Pharmaceutical Co., Ltd. - Pipeline by Top 10 Molecule Type, 2014
Back to Top